ANGN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Angion Biomedica Corp. Is Fair to Shareholders

Author's Avatar
Feb 27, 2023

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Angion Biomedica Corp. (NASDAQ: ANGN) and Elicio Therapeutics is fair to Angion shareholders. Under the terms of the merger agreement, Elicio shareholders will receive newly issued shares of Angion common stock and current Angion shareholders are expected to own approximately 34.5% of the newly combined company.